PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia

JAMA paper provides molecular framework for effect of chromosome deletion in CLL

2011-01-08
(Press-News.org) HOUSTON - The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers reports today in the Jan. 4 edition of the Journal of the American Medical Association.

"Our findings could reveal new mechanisms of resistance to chemotherapy among leukemia patients as this feedback mechanism could help us differentiate between patients with poor or good prognosis," said co-senior author George Adrian Calin, M.D., Ph.D., associate professor in The University of Texas MD Anderson Cancer Center Department of Experimental Therapeutics and co-director of the Center for RNA Interference and Noncoding RNAs.

B cell chronic lymphocytic leukemia (CLL) is the most common form of leukemia among adults, with an estimated 14,990 new cases in 2010 in the United States. It's caused by aberrant versions of infection-fighting B cell lymphocytes, a white blood cell.

Deletion of the long arm of chromosome 13, called 13q, has been associated with less aggressive, or indolent, CLL. In a series of experiments, a team led by Calin and colleagues at MD Anderson and The Ohio State University uncovered the details of that relationship.

"This finding represents the most detailed pathogenetic mechanism involving microRNAs for any human disease," Calin said. MicroRNAs, or miRNAs, are short, single-stranded bits of RNA that regulate the messenger RNA expressed by genes to tell a cell's protein-making machinery which protein to make.

Deletion of 13q unleashes two proteins known to stymie programmed cell death, or apoptosis, a frontline defense against formation and growth of malignant cells, the researchers found. However, it also leads to increased expression of the tumor suppressor gene TP53, which indirectly reduced levels of another protein associated with poor survival among CLL patients. The first effect appears to cause CLL, while the combination of effects keeps it indolent, Calin said.

The team worked with three chromosomal deletions common to CLL:

Deletion 13q, causes the abolition or reduction of two miRNAs: miR-15a and miR-16-1. It's the most common form of deletion, occurring in about 55 percent of CLL cases. Deletion 11q occurs in about 18 percent of CLL cases and affects two other miRNAs: miR-34b and miR-34c. The short arm of chromosome 17, called 17p, is home to the tumor-suppressing gene tumor protein p53, or TP53. It is deleted in about 7 percent of CLL.

Patients with deletions at 11q and 17p experience the most aggressive form of the disease.

The researchers analyzed blood samples from 208 CLL patients, comparing the relative expression and activity of the miRNAs and TP53 depending on the type or types of deletions the patients had.

Normal Conditions, No CLL

With no chromosomal deletions, the microRNAs miR-15a and miR-16-1 inhibit expression of the tumor-suppressor TP53. However, TP53 in turn activates the two miRNAs, which then control expression of two other genes that prevent programmed cell death, or apoptosis. Apoptosis occurs at normal levels, preventing leukemia development.

TP53 also activates the miR34b and miR-34c microRNAs, which then inhibit the gene ZAP70, which is associated with shorter survival among CLL patients.

Why Indolent CLL Follows 13q Deletions

With 13q deletions, miR-15a and miR16-1 are reduced or absent, which allows for increased expression of TP53. This further activates miR-34b and miR-34a, resulting in greater inhibition of Zap70. That's the good part.

With miR-15a and 16-1 gone, expression of the two genes that suppress programmed cell death, BCL2 and MCL1, increases, which allows more aberrant cells to form and grow. While this effect causes slow-growing CLL, the counterweight of suppressed ZAP70 keeps it from getting worse, Calin said.

TP53 is, in effect, a link that joins the two different sets of microRNAs, the researchers noted.

Experiments in acute myeloid leukemia, lung and cervical cancer cell lines indicate the same mechanism may be at work in other cancer types, but more studies will be needed to validate that, Calin said.

This study clears the way for further translational research to identify microRNAs involved in resistance to CLL therapy and therefore poor outcomes for patients, as well as the identification of plasma miRNAs with predictive value for response to therapy. A team led by Calin and study co-author Michael Keating, M.D., professor in MD Anderson's Department of Leukemia, is investigating these topics.

INFORMATION: Carlo Croce, M.D., Ph.D., professor and chairman of the Department of Molecular Virology, Immunology and Medical Genetics at the Comprehensive Cancer Center of The Ohio State University, was co-corresponding author.

Funding for this research was provided by grants from the National Cancer Institute, the U.S. Department of Defense, the NCI-funded MD Anderson Select Programs of Research Excellence in Leukemia and the CLL Global Research Foundation. Also, Muller Fabbri, M.D., is supported by a 2009 Kimmel Scholar Award, Amelia Cimmino, M.D., Ph.D., is supported by a fellowship from the Federazione Italiana Ricera sul Cancro, and Calin has fellowships from the MD Anderson Research Trust and The University of Texas System Regents Research Scholar Program.

Co-authors with Calin and Keating are Masayoshi Shimizu, Riccardo Spizzo, M.D., Ph.D., Milena Nicoloso, M.D., Simona Rossi, Ph.D., Elisa Barbarotto, Ph.D., and Deepa Sampath, Ph.D., all of MD Anderson's Department of Experimental Therapeutics and Center for RNA Interference and Noncoding RNAs; first author Muller Fabbri, M.D., Arianna Bottoni, Ph.D., Nicola Valeri, M.D., Federica Calore, Ph.D., Hansjuerg Alder, Ph.D.. Tatsuya Nakamura, Ph.D., Brett Adair, and Sylwia Wojcik, all of the Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University; Massimo Negrini, Ph.D., Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; Amelia Cimmino, M.D., Ph.D., Institute of Genetics and Physics, National Research Council, Naples, Italy; Francesca Fanini, Ph.D., Ivan Vannini, Ph.D., Gerardo Musuraca, M.D., and Dina Amadori, M.D., of the Istituto Scientifico Romagnolo per lo Studio e la Cura del Tumori, Meldola, Italy; Marie Dell'Aquila, Ph.D., Laura Rassenti, Ph.D., and Thomas Kipps, M.D., Ph.D., of the Department of Medicine, University of California San Diego; Ramana Davuluri, Ph.D., of the Center for Systems and Computational Biology, Wistar Institute, Philadelphia; Neil Kay, M.D., Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn; and Kanti Rai, M.D., Long Island Jewish Medical Center, New Hyde Park, N.Y.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For seven of the past nine years, including 2010,

MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.



ELSE PRESS RELEASES FROM THIS DATE:

Study shows promise for new drug to treat Fragile X

2011-01-08
The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January 5 issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in the larger follow-up clinical trial. The data from the early trial of 30 Fragile X patients, found the drug, called AFQ056, made by Novartis Pharmaceuticals, helped improve symptoms in some patients. Patients who had ...

Blame the 'chaperone'

2011-01-08
A Jackson Laboratory research team led by Professor Patsy Nishina, Ph.D., has identified a mutation in a gene that's essential for correct protein-processing in cells. Defects in protein folding are associated with a variety of abnormalities and diseases. Cells don't come prefabricated, with pieces plunked down and tacked together like modular homes offloaded from trucks. The structural proteins that give cells shape, tubulin and actin (think beams and girders), are themselves subject to essential processing before they become part of the assembly. Proteins must be folded ...

Link between signaling molecules could point way to therapies for epilepsy, stroke, other diseases

2011-01-08
SAN ANTONIO (Jan. 7, 2010) — In the Old West, camps sent smoke signals across distances to share key developments or strategy. Likewise, two important signaling molecules communicate across nerve cells to regulate electrical and chemical activity, neuroscientists from the UT Health Science Center San Antonio reported today. The findings in rodent models have implications for potential future treatment of epilepsy, stroke and other problems, the researchers said. "We now have novel targets for therapeutic intervention for a range of neurological and cardiovascular diseases, ...

Prof. Erantha De Mel Receives The US President's Service Award

2011-01-08
Sri-Lankan born Psychologist / Cognitive Neuroscientist Prof. Erantha De Mel received the President's Call to Service Award at a ceremony held in Washington DC recently. This distinguished service award by President Barack Obama was presented to him for his outstanding services to the American community in the fields of Psychology and Psychotherapy. This lifetime achievement award was established in 2003 after President George W. Bush created the President's Council on Service and Civic Participation. It is given annually to individuals who have dedicated over 4,000 ...

GridBuddy: an award-winning cloud application for the Force.com platform

2011-01-08
Salesforce.com announced that AppBuddy's new application GridBuddy was recognized as one of the top 4 installed applications in the 'Hack into Dreamforce' contest. Awards were given to applications with the highest number of customer AppExchange software installs between 9/20/10 and 11/30/10 leading up to the annual Dreamforce conference. GridBuddy is a 100% native Force.com application that allows users to edit multiple related Salesforce objects using an Excel-like view. GridBuddy has a clean, simple-to-use interface for users to view one parent object with multiple ...

Start Your New Year With A Kick, Women Self-Defense Lessons

2011-01-08
In recent years, programs geared to women only have began to take popularity. From fitness kickboxing classes, boot camps, and women fitness clubs -- women only programs have taken off like a grand slam in baseball. Starting on February 7th, 2011, local martial arts and fitness school owner and instructor, Javier Lozano, Jr. will be teaching a series of 8 Week Women Self-Defense Courses throughout the year. These 8 week courses are designed to teach women the basic fundamentals of empty-hand self-defense by using effective strikes, kicks, and blocks to fend ...

Newly Announced Webinar Compares Agile Software Development from Nearshore and Farshore Viewpoints

2011-01-08
The benefits and risks of IT outsourcing to Latin America will be explored in-depth during a special one-hour webinar coming January 25th at 2 p.m. EST. "The Agile Alternative: What Does Mexico Have that India Doesn't?", hosted by the premiere IT offshoring blog - Nearshore Americas, examines the value proposition of relying on 'nearshore' partners to provide custom application development services. Register today by visiting: http://www.csvep.com/registration/view.php?id=123 Geared toward IT decision makers and managers responsible for software development, testing ...

FoodEnquirer.com - Celebrate The Oat Meal Month And Lower Your Cholesterol

2011-01-08
To start with, it is important that we clear things up. The oatmeal that will give you health benefits are those made from pure oak flakes. The instant oatmeals will do you more harm than good since they have much sugar in them; not to mention traces of preservatives. Having oatmeal for breakfast is a good way to pump you full of energy and start the day. Aside from giving you the boost you need, there are tons of benefits of eating oatmeal. This is why it became a favorite household food item. The first of the obvious benefits of eating oatmeal is it contains fiber, ...

Real World Leader's Institute Co-Founders Debora Mclaughlin And Donna Price, Launch Their Radio Show: Real World Leadership At Blogtalkradio.

2011-01-08
With today's economy and the unique needs of today's work force the face of leadership is changing. Authority driven leadership no longer works and current employee engagement statistics report that only 29% of today's workforce are engaged, reporting to work focused on meeting performance and business outcomes. Successful companies are focusing on educating leaders on employee engagement and current cutting edge leadership strategies to positively affect the bottom line. January 5th, 2011 Debora McLaughlin, CEO of Open Door Coaching and co-founder of The Real World ...

Wall Street Journal: Scoring Unlisted Jobs (80% of job openings are unlisted)

2011-01-08
Job boards are irresistible because they seemingly put everything within easy reach. Unfortunately, the majority of job hunters are competing for the same small pool of jobs and getting turned down. More than 80% of job openings are actually unlisted, says Steven Rothberg, founder of job website CollegeRecruiter.com in Minneapolis. This can be a good opportunity for outside candidates with research and networking skills since most companies will try to promote from within or rely on employee referrals. Look for signs: Keep up with what's going on in your industry. ...

LAST 30 PRESS RELEASES:

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

[Press-News.org] MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia
JAMA paper provides molecular framework for effect of chromosome deletion in CLL